前列腺癌雄激素受体表达与细胞凋亡的关系

目的：探讨前列腺癌雄激素受体与细胞凋亡的关系及其生物学特性，方法：56例前列腺癌和20例良性前列腺增生症，应用免疫组化方法检测石蜡蜡包埋的组织切片中雄激素受体（AR）表达和应用原位末端标记技术（TUNEL）检测细胞凋亡指数（AI）。结果：AR在良恶性前列腺组织中的表达差异无显著性（P＞0．05）。AR和AI与前列腺癌Gleason分级无关。AI在前列腺癌组织中的表达明显高于良性前列腺增生症（P＜0．05），AR阳性的前列腺癌AI亦明显高于AR阴性的前列腺癌。结论：前列腺癌组织中AR的表达可诱导其细胞凋亡，并对前列腺癌的功能性分类和内分泌治疗的疗效判断具有实用的临床意义。

Correlation of apoptosis with androgen receptor in prostate cancer

Purpose　To investigate relationship between androgen receptor and apoptotic index and to further understand the tumor biology of prostate cancer. Methods　Fifty-six patients with histologically proven prostate cancer and 20 cases with benign prostatic hyperplasia(BPH) were collected. Androgen receptor(AR) were stained by 2H12 monoclonal antibody using immunohistochemical method. The apoptotic index (AI) was determined by the terminal deoxynucleotidyl transterase-mediated dUTP biotin nick end labeling (TUNEL) technique on serial sections of formalin fixed, paraffin embedded tissues. Results　AR was not found significantly difference (P>0.05) between prostate cancer and BPH. The association of AR with AI according to Gleason score were not observed in prostate cancer. AI were significantly higher in prostate cancer compared to BPH (P<0.05).AI were also significantly higher in AR-positive prostate cancer than in AR-negative prostate cancer（P<0.05）. Conclusion　AR expression can induce prostate cancer cells to become apoptosis, and may be a useful predictor in functional classification and endocrine response of prostate cancer.